Medicxi
Edit

Medicxi

https://www.medicxi.com
Last activity: 08.04.2024
medicxi is a Life Sciences venture capital firm, with offices in London, St. Helier (Jersey) and Geneva.
Followers
3.19K
News
124
Portfolio
4
Persons
19
Mentions
30
Employees: 11-50
Founded date: 2016
Investment Type: Venture Capital
Investment Stage: Series A; Series B

Portfolio 4

DateNameWebsiteTotal RaisedLocation
23.02.2024Alys Pharm...alyspharma...$100M-
29.06.2022MiroBiomirobio.co...$97.03MUnited Kin...
31.08.2021Versanis B...versanisbi...$70MUnited Sta...
19.11.2020SynOx Ther...synoxthera...$81.8M-

Persons 19

DateFirst NameLast NameTitleLinkedInLocation
-TristanEdwards--
-GiovanniPericolini-linkedin.c...-
-MarieBeaucourt--
-GiuseppeZocco-linkedin.c...-
-MichèleOllier--
-FrancoisPrinsloo--
-ThibaudPortal--
-FrancescoDe Ruberti...-linkedin.c...-
-CharlesGrummitt--
-VictoriaTaylor--
Show more

News 124

DateTitleDescription
23.02.2024Alys Pharmaceuticals launches with $100M financing from Medi...-
30.11.2023Levicept Appoints Eliot Forster as CEO-
27.07.2023Medicxi Announces $400m Medicxi IV-
17.07.2023Medicxi asset-centric portfolio company Versanis Bio to be a...-
30.03.2023Granular Therapeutics to accelerate development of next-gene...-
16.03.2023Aldena Therapeutics Accelerates its Novel and Disruptive App...-
28.11.2022NewAmsterdam Pharma Debuts as Publicly Traded Company Focuse...-
03.10.2022Incyte Announces Agreement to Acquire Medicxi-backed Villari...-
22.08.2022Backed by Medicxi, Novartis vets launch rare blood disorder ...-
04.08.2022Medicxi portfolio company MiroBio to be acquired by Gilead S...-
Show more

Mentions in press and media 30

DateTitleDescriptionSource
08.04.2024D3 Bio Completes Series A+ Round to Advance Innovative Oncol...SHANGHAI, April 8, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focuse...en.prnasia...
23.02.2024Alys Pharmaceuticals launches with $100M financing from Medi...-medicxi.co...
11.02.2024Medicxi merges 6 dermatology biotechs into one, adds $100M f...What do you get when you merge six dermatology disease-focused biotechs into one? Medicxi plans to f...fiercebiot...
02.10.2023'The fundamentals are really strong': Why investors are stay...While the biotech bull market hasn’t charged back in 2023 as many had hoped, European-focused ventur...fiercebiot...
28.07.2023Medicxi IV to boost the European Life sciences sector with $...startuptic...
27.07.2023Medicxi Announces $400m Medicxi IV-medicxi.co...
27.07.2023Medicxi Launches $400M Fund IVMedicxi, a London, UK- Geneva, Switzerland- and Jersey-based life sciences investment firm, announce...finsmes.co...
19.01.2023The Week in Agrifoodtech: Sollum Technologies nabs $30m; pha...Sollum Technologies raised the largest funding round this week, for its programmable LED lighting fo...agfunderne...
17.02.2021Three Cambridge spin-outs join Centessa Pharmaceuticals, lau...Three Cambridge spin-outs join Centessa Pharmaceuticals, launched with a $250m Series A round 17-02-...cambridgen...
19.11.2020SynOx Therapeutics raises €37M in Series A FinancingDUBLIN, Nov. 19, 2020 /PRNewswire/ — SynOx Therapeutics Ltd (“SynOx”), a clinical stage bio pharmace...incubees.c...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In